A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease.

NCT06307626 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
105
Enrollment
INDUSTRY
Sponsor class

Stopped The pre-defined interim analysis concluded that continuing the trials is unlikely to demonstrate the intended efficacy. This decision is not related to safety concerns, and the safety profile of efgartigimod remains unchanged

Conditions

Interventions

Sponsor

argenx